Advertisement

We need your help now

Support from readers like you keeps The Journal open.

You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.

If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.

PA Images
Pfizer

Pfizer's Covid-19 vaccine is 95% effective with no serious side effects, according to trial results

The vaccine has been tested on 43,500 people in six countries.

THE CORONAVIRUS VACCINE from Pfizer is 95% effective and has passed its safety checks, according to further data from the firm.

The pharmaceutical giant and its partner BioNTech published interim results last week showing the jab could prevent more than 90% of people developing Covid-19.

That data was based on the first 94 volunteers to develop Covid-19, but further figures released today are based on the first 170 cases of the virus in the clinical trial.

The vaccine has been tested on 43,500 people in six countries and no safety concerns have been raised.

Another jab, from US firm Moderna, was shown this week in early data to be almost 95% effective.

The Pfizer vaccine has been shown to produce both an antibody and T-cell response in the body to fight coronavirus.

Pfizer and BioNTech expect to be able to produce up to 50 million vaccine doses globally in 2020 and up to 1.3 billion in 2021.

Yesterday, Pfizer chief executive Albert Bourla said the firm is preparing to file for emergency use authorisation from the US Food and Drug Administration.

Your Voice
Readers Comments
189
This is YOUR comments community. Stay civil, stay constructive, stay on topic. Please familiarise yourself with our comments policy here before taking part.
Leave a Comment
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.

    Leave a commentcancel